搜尋





搜尋





Milestone Pharmaceuticals Inc

MIST

添加自選

0.790USD

-0.072-8.35%

交易中 09/24, 14:20（美東）

98.36M總市值

虧損本益比TTM

Milestone Pharmaceuticals Inc

0.790

-0.072-8.35%

財務摘要利潤表資產負債表現金流量表財報公司估值風險評估

概覽

新聞分析

財務

股票評分

技術分析

預測

持股情況

股息

公司資料

財務摘要利潤表資產負債表現金流量表財報公司估值風險評估

MIST 利潤表

您可以在這裡找到Milestone Pharmaceuticals Inc的年度或季度收入報告，以深入了解Milestone Pharmaceuticals Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

營業總收入

--559.00K

--238.00K

--1.55M

--0.00

-100.00%0.00

--0.00

--1.00M

--3.50M

--1.50M

-100.00%0.00

----

--0.00

--15.00M

----

營業收入

--559.00K

--238.00K

--1.55M

--0.00

-100.00%0.00

--0.00

-100.00%0.00

--0.00

--1.00M

----

--1.50M

-100.00%0.00

----

--0.00

--15.00M

----

主營業務成本

--32.00K

--14.00K

----

營業費用

108.99%26.19M

16.46%23.90M

51.48%18.80M

22.24%11.83M

28.83%12.53M

94.64%20.52M

-10.05%12.41M

-37.00%9.68M

-40.82%9.73M

-36.10%10.54M

-20.04%13.80M

-7.08%15.36M

-2.20%16.44M

17.48%16.50M

2.02%17.26M

15.81%16.53M

17.62%16.81M

11.54%14.05M

93.08%16.92M

18.11%14.27M

9.03%14.29M

-24.85%12.59M

-53.62%8.76M

-11.95%12.09M

-8.57%13.11M

53.32%16.76M

86.92%18.89M

137.25%13.72M

289.93%14.33M

156.87%10.93M

--10.11M

--5.79M

--3.68M

--4.25M

研發費用

-4.36%3.51M

-34.69%3.25M

37.85%5.52M

-2.09%3.94M

27.40%3.67M

34.29%4.98M

-26.54%4.00M

-40.13%4.02M

-66.60%2.88M

-63.86%3.71M

-48.46%5.45M

-31.60%6.72M

-19.10%8.62M

16.98%10.26M

-3.10%10.58M

0.96%9.83M

13.05%10.66M

2.01%8.77M

89.32%10.92M

18.29%9.73M

9.34%9.43M

-27.60%8.60M

-59.25%5.77M

-13.80%8.23M

-18.10%8.62M

52.89%11.87M

93.90%14.15M

144.06%9.54M

312.66%10.53M

151.21%7.76M

--7.30M

--3.91M

--2.55M

--3.09M

折舊攤銷及損耗

103.57%57.00K

107.41%56.00K

30.77%34.00K

0.00%25.00K

7.69%28.00K

-3.57%27.00K

0.00%26.00K

4.17%25.00K

8.33%26.00K

55.56%28.00K

73.33%26.00K

-11.11%24.00K

0.00%24.00K

-21.74%18.00K

-34.78%15.00K

12.50%27.00K

4.35%24.00K

0.00%23.00K

-8.00%23.00K

4.35%24.00K

-8.00%23.00K

-4.17%23.00K

4.17%25.00K

155.56%23.00K

1150.00%25.00K

700.00%24.00K

1100.00%24.00K

200.00%9.00K

-33.33%2.00K

50.00%3.00K

--2.00K

--3.00K

--2.00K

其他營業費用

----

--14.00K

----

營業利潤

-104.53%-25.63M

-15.30%-23.66M

-39.02%-17.26M

-22.24%-11.83M

-28.83%-12.53M

-94.64%-20.52M

10.05%-12.41M

37.00%-9.68M

40.82%-9.73M

31.98%-10.54M

-0.30%-13.80M

-2.20%-15.36M

2.20%-16.44M

-10.36%-15.50M

18.67%-13.76M

-5.30%-15.03M

-2460.39%-16.81M

-11.54%-14.05M

-93.08%-16.92M

-18.11%-14.27M

105.43%712.00K

24.85%-12.59M

53.62%-8.76M

11.95%-12.09M

8.57%-13.11M

-53.32%-16.76M

-86.92%-18.89M

-137.25%-13.72M

-289.93%-14.33M

-156.87%-10.93M

---10.11M

---5.79M

---3.68M

---4.25M

淨非營業利息收入（費用）

利息收入

237.40%1.74M

148.49%1.73M

-7.85%833.00K

-19.07%874.00K

-56.49%516.00K

-29.88%697.00K

-13.58%904.00K

-3.57%1.08M

-2.23%1.19M

80.07%994.00K

79.73%1.05M

136.29%1.12M

667.72%1.21M

1280.00%552.00K

1611.76%582.00K

887.50%474.00K

172.41%158.00K

-50.00%40.00K

-64.58%34.00K

-46.07%48.00K

-53.97%58.00K

-80.72%80.00K

-84.08%96.00K

-89.16%89.00K

-81.25%126.00K

-17.00%415.00K

35.20%603.00K

865.88%821.00K

655.06%672.00K

455.56%500.00K

--446.00K

--85.00K

--89.00K

--90.00K

利息費用

396.85%4.72M

342.25%4.13M

7.18%985.00K

7.09%967.00K

7.22%951.00K

7.22%935.00K

7.23%919.00K

7.37%903.00K

8.17%887.00K

--872.00K

--857.00K

--841.00K

--820.00K

----

稅前利潤

-120.68%-28.61M

-25.55%-26.07M

-40.08%-17.41M

-25.49%-11.92M

-37.53%-12.97M

-99.20%-20.76M

8.69%-12.43M

37.01%-9.50M

41.23%-9.43M

30.29%-10.42M

-3.29%-13.61M

-3.61%-15.08M

3.63%-16.04M

-6.73%-14.95M

21.96%-13.18M

-2.33%-14.56M

-2262.08%-16.65M

-11.93%-14.01M

-94.83%-16.88M

-18.58%-14.22M

105.93%770.00K

23.43%-12.51M

52.62%-8.67M

7.04%-12.00M

5.00%-12.98M

-56.69%-16.34M

-89.31%-18.29M

-126.39%-12.90M

-280.88%-13.66M

-150.42%-10.43M

---9.66M

---5.70M

---3.59M

---4.17M

所得稅

----

---65.00K

---61.00K

---65.00K

---68.00K

----

--0.00

100.00%0.00

----

100.00%0.00

76.71%-17.00K

----

-100.00%0.00

-101.79%-1.00K

---73.00K

-300.00%-4.00K

37.50%22.00K

--56.00K

--0.00

--2.00K

--16.00K

除稅後利潤

-120.68%-28.61M

-25.55%-26.07M

-40.82%-17.41M

-26.31%-11.92M

-38.48%-12.97M

-100.51%-20.76M

9.17%-12.36M

37.41%-9.44M

41.64%-9.36M

30.74%-10.35M

-3.29%-13.61M

-3.61%-15.08M

3.63%-16.04M

-6.73%-14.95M

21.96%-13.18M

-2.33%-14.56M

-2262.08%-16.65M

-11.93%-14.01M

-94.83%-16.88M

-18.75%-14.22M

105.93%770.00K

23.43%-12.51M

52.61%-8.67M

6.64%-11.98M

4.97%-12.98M

-56.36%-16.34M

-88.21%-18.29M

-125.11%-12.83M

-280.55%-13.66M

-149.99%-10.45M

---9.72M

---5.70M

---3.59M

---4.18M

持續經營利潤

-120.68%-28.61M

-25.55%-26.07M

-40.82%-17.41M

-26.31%-11.92M

-38.48%-12.97M

-100.51%-20.76M

9.17%-12.36M

37.41%-9.44M

41.64%-9.36M

30.74%-10.35M

-3.29%-13.61M

-3.61%-15.08M

3.63%-16.04M

-6.73%-14.95M

21.96%-13.18M

-2.33%-14.56M

-2262.08%-16.65M

-11.93%-14.01M

-94.83%-16.88M

-18.75%-14.22M

105.93%770.00K

23.43%-12.51M

52.61%-8.67M

6.64%-11.98M

4.97%-12.98M

-56.36%-16.34M

-88.21%-18.29M

-125.11%-12.83M

-280.55%-13.66M

-149.99%-10.45M

---9.72M

---5.70M

---3.59M

---4.18M

歸属于母公司的淨利潤

-120.68%-28.61M

-25.55%-26.07M

-40.82%-17.41M

-26.31%-11.92M

-38.48%-12.97M

-100.51%-20.76M

9.17%-12.36M

37.41%-9.44M

41.64%-9.36M

30.74%-10.35M

-3.29%-13.61M

-3.61%-15.08M

3.63%-16.04M

-6.73%-14.95M

21.96%-13.18M

-2.33%-14.56M

-2262.08%-16.65M

-11.93%-14.01M

-94.83%-16.88M

-18.75%-14.22M

105.93%770.00K

23.43%-12.51M

52.61%-8.67M

6.64%-11.98M

4.97%-12.98M

-56.36%-16.34M

-88.21%-18.29M

-125.11%-12.83M

-280.55%-13.66M

-149.99%-10.45M

---9.72M

---5.70M

---3.59M

---4.18M

歸屬普通股東的淨利潤

-120.68%-28.61M

-25.55%-26.07M

-40.82%-17.41M

-26.31%-11.92M

-38.48%-12.97M

-100.51%-20.76M

9.17%-12.36M

37.41%-9.44M

41.64%-9.36M

30.74%-10.35M

-3.29%-13.61M

-3.61%-15.08M

3.63%-16.04M

-6.73%-14.95M

21.96%-13.18M

-2.33%-14.56M

-2262.08%-16.65M

-11.93%-14.01M

-94.83%-16.88M

-18.75%-14.22M

105.93%770.00K

23.43%-12.51M

52.61%-8.67M

6.64%-11.98M

4.97%-12.98M

-56.36%-16.34M

-88.21%-18.29M

-125.11%-12.83M

-280.55%-13.66M

-149.99%-10.45M

---9.72M

---5.70M

---3.59M

---4.18M

基本每股收益

-5.62%-0.21

36.12%-0.20

11.99%-0.16

13.36%-0.12

-38.03%-0.20

-88.10%-0.39

40.98%-0.19

59.37%-0.14

62.13%-0.14

40.82%-0.21

-2.63%-0.32

-2.45%-0.35

5.11%-0.37

-5.21%-0.35

23.00%-0.31

-1.58%-0.34

-2230.79%-0.39

-9.32%-0.33

-35.44%-0.40

16.18%-0.34

103.51%0.02

54.44%-0.30

53.04%-0.30

23.21%-0.40

8.75%-0.53

-50.62%-0.67

-53.05%-0.63

-117.35%-0.52

-280.55%-0.58

-149.99%-0.44

---0.41

---0.24

---0.15

---0.18

稀釋每股收益

-5.62%-0.21

36.12%-0.20

11.99%-0.16

13.36%-0.12

-38.03%-0.20

-88.10%-0.39

40.98%-0.19

59.37%-0.14

62.13%-0.14

40.82%-0.21

-2.63%-0.32

-2.45%-0.35

5.11%-0.37

-5.21%-0.35

23.00%-0.31

-1.58%-0.34

-2230.79%-0.39

-9.32%-0.33

-35.44%-0.40

16.18%-0.34

103.51%0.02

54.44%-0.30

53.04%-0.30

23.21%-0.40

8.75%-0.53

-50.62%-0.67

-53.05%-0.63

-117.35%-0.52

-280.55%-0.58

-149.99%-0.44

---0.41

---0.24

---0.15

---0.18

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Milestone Pharmaceuticals Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 MIST 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Milestone Pharmaceuticals Inc 財年末的營收是多少？



Milestone Pharmaceuticals Inc 2025 財年營收為 1.55M，高於上一財年的 1.55M。

Milestone Pharmaceuticals Inc 全年的淨利潤是多少？



Milestone Pharmaceuticals Inc 2025 財年淨利潤為 -63.06M。

Milestone Pharmaceuticals Inc 上一季度的淨利潤是多少？



Milestone Pharmaceuticals Inc 最近一個季度的淨利潤為 -28.61M。

Milestone Pharmaceuticals Inc 年度營業利潤是多少？



Milestone Pharmaceuticals Inc 2025 財年的營業利潤為 -62.48M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。